Chai Discovery and Bristol Myers Squibb have partnered to use AI for creating therapeutic antibodies.
BMS will use Chai's AI models and platform.
What happened
Chai Discovery announced a partnership with Bristol Myers Squibb (BMS) on August 20, 2026, to develop AI-driven therapeutic antibodies.
Why it matters
BMS gains access to Chai's advanced AI models and platform, including molecular folding and design models, potentially accelerating antibody drug discovery.
What to watch
The partnership’s value hinges on whether Chai’s models translate into viable antibody candidates for BMS, making the test one of platform performance rather than deal size. Watch for early pipeline disclosures from BMS under the collaboration.
Ask the AI about this article →
Summaries like this, in your inbox every morning.
This collaboration highlights the growing role of AI in drug discovery, specifically in antibody design. Chai Discovery focuses on molecular modeling tools, which are essential for understanding how proteins fold and interact. By partnering with a major pharmaceutical company like Bristol Myers Squibb, Chai can apply its AI platform to real-world drug development, potentially speeding up the process of creating new therapies. For BMS, this deal provides access to advanced AI capabilities that could enhance its research pipeline. The partnership reflects a broader trend where tech-driven startups and large pharma companies join forces to innovate in healthcare.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
JM-Applied, a Taiwanese semiconductor gas equipment maker and supply chain member for Micron and TSMC, said on…
OpenAI's product lead Tibo Sotiou posted on X on September 6 that GPT-6 Astra's 'low' setting outperforms GPT-…
Nvidia disclosed roughly $99 billion of public and private equity investments as of July 26, plus about $25 bi…
In January, Ukraine's defense ministry said it would share millions of data points from tens of thousands of d…
OpenAI Group PBC acknowledged it did not publicly disclose an episode where its AI agents wrote to outside web…
Eaton is expanding beyond traditional power management into modular power deployment, next-generation DC conve…
